These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2517496)

  • 1. Molecular distribution of gold(I) in human blood plasma after treatment with the antiarthritic disodium aurothiomalate.
    Rayner MH; Grootveld M; Sadler PJ
    Int J Clin Pharmacol Res; 1989; 9(6):377-83. PubMed ID: 2517496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protein binding of gold in serum of patients treated with different gold preparations].
    Herrlinger JD; Weikert W
    Z Rheumatol; 1982; 41(5):230-4. PubMed ID: 6818790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold concentrations in blood fractions of patients with rheumatoid arthritis treated with Myocrisin.
    Egila J; Littlejohn D; Smith WE; Sturrock RD
    J Pharm Biomed Anal; 1992 Sep; 10(9):639-44. PubMed ID: 1286129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro distribution of gold in serum proteins after incubation of sodium aurothiomalate and auranofin with human blood and its pharmacological significance.
    Iqbal MS; Taqi SG; Arif M; Wasim M; Sher M
    Biol Trace Elem Res; 2009 Sep; 130(3):204-9. PubMed ID: 19194667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of gold in plasma and plasma fractions by atomic absorption spectrometry and by neutron activation analysis.
    Ward RJ; Danpure CJ; Fyfe DA
    Clin Chim Acta; 1977 Nov; 81(1):87-97. PubMed ID: 411614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of smoking on the distribution of gold in blood.
    Graham GG; Haavisto TM; McNaught PJ; Browne CD; Champion GD
    J Rheumatol; 1982; 9(4):527-31. PubMed ID: 6813468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats.
    Garrett IR; Whitehouse MW; Vernon-Roberts B; Brooks PM
    J Rheumatol; 1985 Dec; 12(6):1079-82. PubMed ID: 3937896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating thiomalate after administration of disodium aurothiomalate: impurity or active metabolite?
    Rudge SR; Perrett D; Swannell AJ; Drury PL
    J Rheumatol; 1984 Apr; 11(2):150-2. PubMed ID: 6427462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of gold in serum erythrocytes and white blood cells after in vitro incubation and during chrysotherapy with different gold compounds.
    Herrlinger JD; Alsen C; Beress R; Hecker U; Weikert W
    J Rheumatol Suppl; 1982; 8():81-9. PubMed ID: 6813496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.
    Danpure CJ; Fyfe DA; Gumpel JM
    Ann Rheum Dis; 1979 Aug; 38(4):364-70. PubMed ID: 115389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of cigarette smoking on blood gold distribution during chrysotherapy.
    James DW; Ludvigsen NW; Cleland LG; Milazzo SC
    J Rheumatol; 1982; 9(4):532-5. PubMed ID: 6813469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracellular gold content of circulating blood cells using various gold compounds].
    Herrlinger JD; Beress R; Hecker U
    Wien Klin Wochenschr Suppl; 1984; 156():13-6. PubMed ID: 6442048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of sodium aurothiomalate during lactation.
    Bennett PN; Humphries SJ; Osborne JP; Clarke AK; Taylor A
    Br J Clin Pharmacol; 1990 Jun; 29(6):777-9. PubMed ID: 2116162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of 'free' gold in patients receiving disodium aurothiomalate and the association of high free to total gold levels with toxicity.
    Heath MJ
    Ann Rheum Dis; 1988 Jan; 47(1):18-21. PubMed ID: 3125798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid biotransformation of satraplatin by human red blood cells in vitro.
    Carr JL; Tingle MD; McKeage MJ
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):9-15. PubMed ID: 12111106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of protein-bound gold in rat urine following aurothiomalate administration and of rat and human albumin-gold-thiomalate.
    Shaw CF; Schaeffer-Memmel N; Krawczak D
    J Inorg Biochem; 1986 Mar; 26(3):185-95. PubMed ID: 3084707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter.
    Gerber RC; Paulus HE; Jennrich RI; Lederer M; Bluestone R; Blahd WH; Pearson CM
    J Lab Clin Med; 1974 May; 83(5):778-89. PubMed ID: 4207022
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
    Iqbal MS; Saeed M; Taqi SG
    Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [[Gold antirheumatic drug: desired and adverse effects of Au(I) and Au(III) [corrected] on the immune system].
    Griem P; Gleichmann E
    Z Rheumatol; 1996; 55(5):348-58. PubMed ID: 9036720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium aurothiomalate, gold keratinate, and various tetracyclines in mycoplasma-induced arthritis of rodents.
    Hannan PC
    J Med Microbiol; 1977 Feb; 10(1):87-102. PubMed ID: 402475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.